Be part of an exclusive global network of angel investors, VCs and corporate VCs driving innovation in healthtech startups through DayOne’s acceleration program and alumni network.
Join the DayOne Healthtech Investor Community

Where innovation meets investment
Why join our community?
Access to high-potential startups
Gain early access to vetted healthtech startups from our accelerator program and alumni network — spanning digital health, AI in medicine, medical devices and more.
Curated introductions
We facilitate 1:1 introductions tailored to your investment priorities — connecting you with founders seeking strategic partnerships and funding.
Exclusive events & pitching competitions
Join private pitch events, flagship events, innovation showcases and roundtables with healthtech innovators, and network with like-minded investors.
Insider insights & reports
Receive investor reports with portfolio updates, market trends, and emerging opportunities in the healthtech space.
Engage & collaborate
Be part of an active investor community — share expertise, network, co-invest, and join our selection juries to help identify the next wave of groundbreaking startups.
Featured event: DayOne Innovation Showcase
Want the chance to see the world’s most innovative healthtech startups pitch?
The Innovation Showcase is held in December, at the culmination of each year’s DayOne Accelerator program and international startups from the accelerator program and an open call for application.
It is an elite space tailor-made for investors and startups, fostering networking, pitching, business exploration and a deep dive into the healthtech startup ecosystem.

Meet the DayOne team
Members of our team will be attending the events listed below. If you are interested in meeting up onsite, please reach out to the relevant person:
Clinical Genomic Biomarkers Summit 2025
Roche Building, Basel
24.06.25
Sachs 12th Annual Healthtech Investment Forum
Mövenpick Hotel, Basel
07.10.2025
AI & Digital Health Transforming Clinical Trials
Novartis Campus, Basel
29.10.2025
DxPx Europe ‘26
Leonardo Royal Munich, Munich
05-06.02.2026
Health Tech Global Summit
Messe, Basel
03-05.03.2026
Portfolio
The DayOne Accelerator has helped launch more than 40 innovative healthtech ventures since we started operating in 2018. You can find details of all our active alumni companies here.
Frequently Asked Questions
What is the DayOne Accelerator program?
The DayOne Accelerator supports international healthtech startups across the innovation spectrum, helping them navigate early-stage challenges, secure funding and scale. Through tailored support, access to industry leaders, seasoned mentors, and a robust network of partners and investors, the program empowers startups to refine their strategy and accelerate growth.
Over the course of three months, participants sharpen their value propositions, engage with key players in the life sciences ecosystem, and position themselves for long-term success. Top-performing startups may receive follow-on funding and extended support.
The program is based in Basel, Switzerland – Europe’s leading hub for life sciences innovation.
How is the program funded?
DayOne is a non-profit organisation, supported by a blend of public and private funding. The program does not take equity in the startups (during or after the accelerator).
Backed by the Basel-Stadt Kanton and operating under the umbrella of Basel Area Business and Innovation, DayOne offers lasting stability and strong public-sector support.
What type of companies does the accelerator focus on?
The DayOne program targets startups in digital health, medtech and techbio that are developing solutions for pharma R&D. We focus on companies from Pre-Seed to Series A stage that have raised under $10m in dilutive funding and are seeking collaboration or partnership with major pharmaceutical players. Our portfolio is globally diverse, with alumni from Europe, Asia and North America.
What type of investors is DayOne looking for?
Our investor community includes venture capital firms, corporate VCs, business angels and family offices. We seek investors with an active interest in healthtech – ideally with a dedicated fund or portfolio – and a focus on Pre-Seed to Series A investments. While our network is global, most investors backing our startups are based in Switzerland, the EU, the UK and the US.
What do the startups get?
The DayOne Accelerator is a three-month hybrid program designed to connect healthtech startups with key pharma and medtech leaders. It offers one-on-one mentorship from senior industry executives, expert-led learning sessions, investor connections, funding pathways, and pitch opportunities with industry partners.
Why should I get involved? How does it differ from other accelerator programs?
Only the most promising startups, selected from a large competitive pool, receive investment. Each opportunity is rigorously vetted through our accelerator program, ensuring a derisked, high-quality deal flow. DayOne takes no equity during or after the accelerator, focusing instead on long-term success and value creation. Backed by Basel-Stadt Kanton and operating under Basel Area Business and Innovation, DayOne provides stability and strong public support.
Investments are structured through convertible notes, offering downside protection and upside potential. Investors choose which startups to back and help shape the long-term support plans. The Basel ecosystem is an exceptional launchpad for R&D-driven ventures, offering access to customers, labs, talent, infrastructure and strategic exit opportunities. Our engagement continues beyond investment, with tailored mentorship, non-dilutive funding, network access, space at Switzerland Innovation Park and additional resources to support startups as they grow into valuable life science partners.
What are the benefits for me as an investor?
As an investor, you’ll gain access to a curated, actively managed pipeline of high-potential healthtech startups – enhancing deal flow and reducing investment risk. The program facilitates one-on-one meetings with ventures aligned to your interests and offers exclusive networking within the DayOne investor community, enabling co-investment opportunities.
As a founding investor in the DayOne program, what are the expectations from me? And what is the role of DayOne?
DayOne acts as a facilitator and strategic matchmaker – connecting investors and industry partners with a curated selection of high-potential healthtech startups poised for market traction. Leveraging deep sector expertise and a clear understanding of industry challenges, we create streamlined, lower-risk investment and co-investment opportunities tailored for long-term impact.
As a founding investor, you’ll play an active role on the Accelerator selection committee alongside industry experts – giving you direct influence over which startups receive investment and how the long-term support program is shaped. You gain early access to the startups, enabling you to guide their development and ensure they are investment-ready within three months. You also receive expert evaluations from regulatory, IP, and legal partners, along with feedback from pharma executives, to support well-informed investment decisions.
How do I invest? What if I have more questions?
Reach out to us directly here for more information.
Join us today!
Ready to connect with the most innovative startups in healthtech?
If so, join the community and sign up for our quarterly investor newsletter via the form.